|
|
|
|
| LEADER |
01022cam#a22002894a#4500 |
| 005 |
20051221140947.0 |
| 008 |
991005s2000####nyu######b####001#0#eng## |
| 001 |
BCCAB004363 |
| 003 |
AR-BCCAB |
| 245 |
1 |
0 |
|a Design and analysis of bioavailability and bioequivalence studies /
|c Shein-Chung Chow, Jen-pei Liu.
|
| 250 |
# |
# |
|a 2nd ed., rev. and expanded.
|
| 260 |
# |
# |
|a New York :
|b M. Dekker,
|c c2000.
|
| 300 |
# |
# |
|a xii, 584 p. ;
|c 24 cm.
|
| 490 |
1 |
# |
|a Biostatistics ;
|v 3
|
| 020 |
# |
# |
|a 0824775724 (alk. paper) :
|c U$S190
|
| 100 |
1 |
# |
|a Chow, Shein-Chung,
|d 1955-
|
| 700 |
1 |
# |
|a Liu, Jen-pei,
|d 1952-
|
| 650 |
# |
0 |
|a Bioavailability
|x Research
|x Statistical methods.
|
| 650 |
# |
0 |
|a Drugs
|x Therapeutic equivalency
|x Research
|x Statistical methods.
|
| 010 |
# |
# |
|a ###99051464#
|
| 050 |
0 |
0 |
|a RM301.6
|b .C46 2000
|
| 504 |
# |
# |
|a Incluye referencias bibliográficas.
|
| 040 |
# |
# |
|a DLC
|c DLC
|d DLC
|b spa
|d arbccab
|
| 500 |
# |
# |
|a Incluye índice.
|
| 082 |
0 |
0 |
|a 615/.7
|2 21
|
| 942 |
# |
# |
|c BK
|
| 952 |
# |
# |
|2 udc
|a ARBCCAB
|b ARBCCAB
|i 18460
|o 614.7 Ch459 Ed.2
|p 18460
|t 1
|y BK
|
